Bone Growth Stimulators Market Size To Hit USD 3.45 Bn By 2033

The global bone growth stimulators market size was USD 1.89 billion in 2023, is estimated at USD 2.01 billion in 2024, and is projected to hit around USD 3.45 billion by 2033, expanding at a CAGR of 6.2% from 2024 to 2033.

By administering electrical or ultrasonic current to the fracture/fusion site, bone growth stimulation is used to stimulate bone healing in fractures or fusions that are difficult to heal. An instrument called an electrical osteogenesis stimulator delivers electrical stimulation to speed up bone healing.

Many orthopedists advise using this technology to encourage quicker bone repair. In order to stimulate bone development, stimulators deliver painless electrical or ultrasonic stimulation. It operates by producing either pulsed ultrasonic energy or a low-level pulsed electromagnetic field. The idea is that by assisting the body in tissue healing and promoting cell creation and maturity, these energy fields drive bone growth, increasing bone density.

Table of Contents

Bone Growth Stimulators Market Key Points

North America region has accounted for nearly 41.64% of the total revenue share in 2023.
Asia-Pacific is anticipated to grow at a CAGR of 6.8% from 2024 to 2033.
By product, the bone growth stimulation devices segment has garnered a 52.4% revenue share in 2023.
By application, spinal fusion surgeries held a 47% market share in 2023.

Regional Snapshots

North America held dominant position and predicted to be in the dominating state during forecast period. The significant market share of North America can be ascribed to the region’s highly developed healthcare infrastructure and reimbursement system as well as the rising awareness among physicians and patients of the most recent treatments and technologies available today.

Further propelling the growth of the North American bone growth stimulator market are the rising prevalence of spinal disorders, growing geriatric population, rising population exposure to major risk factors such as obesity, smoking, and diabetes, and rising patient preference for minimally invasive orthopedic therapies.

Bone Growth Stimulators Market Report Highlights

On the basis of product type, the bone growth stimulation devices segment is the leading segment and is expected to make the largest contribution to the bone growth stimulators market. This can be ascribed to the rising occurrence of nonunion fractures, the rising geriatric population, and the rising preference for nonsurgical treatment options. In addition, after surgery or trauma, bone regeneration can be slowed down or prevented by a number of variables, including obesity, smoking, and diabetes. The prevalence of these risk factors is increasing, which will support the market expansion for bone growth stimulators.
On the basis of application, the highest CAGR is projected for the spinal fusion segment during the forecasted period. Spinal fusion procedures are performed to permanently join two or more vertebrae and stop motion between them. Products that promote bone growth are used before, during, and after operations to promote the natural process of bone formation. The ageing population, the rise in spine surgeries, the safety and effectiveness of stimulators in fusion surgery, and the rising use of bone growth stimulation devices are all factors contributing to the growth of this market.
On the basis of end-user, hospitals to be in dominant position in bone growth stimulators market during forecast period. Hospital facilities host a large number of patient visits and numerous orthopedic treatments, which accounts for the dominance. The enormous number of hospitals worldwide, in both developed and underdeveloped countries. The reason for the segment’s dominance is that government hospitals are essential for providing subsidized care in many areas, particularly in emerging markets.

Bone Growth Stimulators Market Scope

Report Coverage	Details
Market Size in 2023	USD 1.89 Billion
Market Size in 2024	USD 2.01 Billion
Market Size by 2033	USD 3.45 Billion
Growth Rate from 2024 to 2033	CAGR of 6.2%
Base Year	2023
Forecast Period	2024 to 2033
Segments Covered	Product, Application, and End User
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics

Drivers

One of the key drivers of the use of such stimulators and, consequently, the growth of the market, is the rising incidence of bone diseases across the globe. One of the main causes of fractures worldwide is osteoporosis. More than 8.9 million fractures are thought to be caused by the illness each year, which affects 75 million individuals in the U.S., Europe, and Japan. Additionally, the rapid development of technologically sophisticated products for effective treatment together with the rising prevalence of such disorders would promote market expansion. Additionally, the rise in oral and maxillofacial operations worldwide will help the market’s expansion. Humans always start growing bone, therefore when a bone is broken, the body has a remarkable capacity to heal the fracture on its own. With the right care, which may involve realignment, casts, and surgery, the majority of patients who break a bone will recover. But because bones are formed of living tissue, a fatigue crack causes two shattered ends to break, one of which is positively charged and the other negatively charged. It is possible to implant the stimulator either above or below the skin.

Due to the benefits that these procedures provide over conventional treatment methods, the demand for minimally invasive procedures has increased significantly. Fewer postoperative complications, a shorter hospital stay, less pain, smaller and more cosmetic incisions, a lower risk of infection, less postoperative care, and a speedier recovery time are the main benefits of minimally invasive operations. Modern technology is used in minimally invasive procedures to identify and treat diseases like cancer. These operations are a successful method for removing lymph nodes and cancerous tumors without leaving scars.

Restraints

One of the key elements influencing the acceptance and demand of particular diagnostic or therapeutic items among patients and healthcare professionals at a national level is medical reimbursement. In developed nations, the majority of healthcare insurance companies cover products that stimulate bone formation if certain conditions are met. Australia’s Transport Accident Commission (TAC) offers payment for implantable or externally applied bone growth stimulation devices in the event that a transport accident results in injuries. However, a lot of private insurance companies do not offer coverage or reimbursement for procedures that stimulate bone formation. These factors are restraining the growth of the bone growth stimulators market.

Opportunities

The market for bone growth stimulators is predicted to have significant growth potential in emerging economies. The demand for bone growth stimulation products in these nations is anticipated to increase as a result of factors including the presence of a sizable patient population, rising healthcare spending, government initiatives to support the healthcare industry, and growing awareness among doctors, surgeons, and patients about the most recent treatment options for spinal fusion and bone healing. Additionally, it has been stated that many patients from established markets migrate to these developing nations for medical care due to the huge cost advantages. The cost of treatment in developing nations are less than the most developed nations hence, the rising economies regions are expected to host more patients.

Challenges

Bone morphogenetic proteins have a few negative effects, despite being utilized more frequently in spinal fusion and bone repair. The main adverse consequences of BMPs following spinal fusion surgery include implant dislodgment, tissue inflammation, and male infertility. According to reports, BMPs activate oncogenes and trigger antigenic responses during bone repair. During the use of its BMP product in spinal fusion procedures for bone repair, Medtronic identified a number of clinical problems related to it.

Bone Growth Stimulators Market Companies

Orthofix Medical, Inc.
DJO Finance, LLC
BTT Health GmbH
Stimulate Health Inc
Zimmer Biomet
Elizur Corporation.
Kinex Medical Company, LLC
Fintek Bio-Electric Inc.
Bioventus LLC
Medtronic plc
Stryker (US), DePuy Synthes
Arthrex, Inc.
Isto Biologics
Terumo Corporation
Ember Therapeutics, Inc.
Ossatec Benelux Ltd.
Regen Lab SA
ITO Co., Ltd.
Biomedical Tissue Technologies Pty Ltd.

Recent Developments

Stryker Corp., a manufacturer of medical devices, announced that it would acquire smaller rival Wright Medical Group for nearly $4 billion in cash, allowing it to enter the rapidly increasing market for wrist and shoulder implants. The purchase would propel Stryker to become one of the market leaders in implants for the treatment of bone fractures as well as joint replacements. It is the most recent in a string of consolidations in the medical device industry.

Segments covered in the report

By Product